Heavy Metal Enlightens Tumor Immunity.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28475889.
- Also identified by DOI 10.1016/j.cell.2017.04.017 and PMC identifier 6597172.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A deep understanding of the immune landscape in human cancer is essential for guiding the development of immunotherapy to benefit more patients with long-lasting efficacy. Now, two studies from Lavin et al. and Chevrier et al. employ mass cytometry to study immune infiltrates in lung adenocarcinoma and clear cell renal cell carcinoma, respectively.
Medical subject headings
- Carcinoma, Renal Cell
- Immunotherapy